Using Case Management to Increase Antiinflammatory Medication Use Among a Managed Care Population with Asthma

REFERENCES

• Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD 1997
   Google Scholar
• Diette G.B., Wu A.W., Skinner E.A., Markson L., Clark R.D., McDonald R.C., Healy J.P., Jr., Huber M., Steinwachs D.M. Treatment Patterns Among Adult Patients with Asthma: Factors Associated with Overuse of Inhaled Beta-Agonists and Underuse of Inhaled Corticosteroids. Arch. Intern. Med. 1999; 159(22)2697–2704
   Google Scholar
• Rocchiccioli K.M.S., Riley P.A. Clinical Pharmacology of Nedocromil Sodium. Drugs 1989; 37(suppl 1)123–126
   Google Scholar
• Edwards A.M. Sodium Cromoglycate (Intal) as an Anti-inflammatory Agent for the Treatment of Chronic Asthma. Clin. Exp. Allergy 1994; 24(7)612–623
   Google Scholar
• D’Alonzo G.E., Nathan R.A., Henochowicz S., Morris R.J., Ratner P., Rennard S.I. Salmeterol Xinofoate as Maintenance Therapy Compared with Albuterol in Patients with Asthma. JAMA 1994; 271(18)1412–1416
   PubMedGoogle Scholar
• Sullivan P., Bekir S., Jaffar Z., Page C., Jeffrey P., Costello J. Anti-inflammatory Effects of Low-Dose Oral Theophylline in Atopic Asthma. Lancet 1994; 343(8904)1006–1008
   PubMed Web of Science ®Google Scholar
• D’Urzo A.D., Chapman K.R. Leukotriene-Receptor Antagonists: Role in Asthma Management. Can. Fam. Physician 2000; 46(4)872–879
   Google Scholar
• Kelsen S.G., Church N.L., Gillman S.A., Lanier B.Q., Emmett A.H., Rickard K.A., Anderson W.H. Salmeterol Added to Inhaled Corticosteroid Therapy Is Superior to Doubling the Dose of Inhaled Corticosteroids: A Randomized Clinical Trial. J. Asthma 1999; 36(8)703–715
   Web of Science ®Google Scholar
• Van Noord J.A., Schreurs A.J., Mol S.J., Mulder P.G. Addition of Salmeterol Versus Doubling the Dose of Fluticasone Propionate in Patients with Mild to Moderate Asthma. Thorax 1999; 54(3)207–212
   PubMed Web of Science ®Google Scholar
• Baraniuk J., Murray J.J., Nathan R.A., Berger W.E., Johnson M., Edwards L.D., Srebro S., Rickard K.A. Fluticasone Alone or in Combination with Salmeterol vs. Triamcinolone in Asthma. Chest 1999; 116(3)624–632
   Google Scholar
• Virchow J., Hassall S.M., Summerton L., Klim J., Harris A. Reduction of Asthma Exacerbations with Zafirlukast in Patients on Inhaled Corticosteroids. Eur. Respir. J. 1997; 10(suppl 25)420S
   Google Scholar
• Selroos O., Pietinalho A., Lofroos A.B., Riska H. Effect of Early vs. Late Intervention with Inhaled Corticosteroids in Asthma. Chest 1995; 108(5)1228–1234
   PubMed Web of Science ®Google Scholar
• Suissa S., Ernst P., Benayoun S., Baltzan M., Cai B. Low-Dose Inhaled Corticosteroids and the Prevention of Death from Asthma. N. Engl. J. Med. 2000; 343(5)332–336
   PubMed Web of Science ®Google Scholar
• Donahue J.G., Weiss S.T., Livingston J.M., Goetsch M.A., Greineder D.K., Platt R. Inhaled Steroids and the Risk of Hospitalization for Asthma. JAMA 1997; 277(11)887–891
   PubMed Web of Science ®Google Scholar
• Drazen J.M., Israiel E., Boushey H.A., Chinchilli V.M., Fahy J.V., Fish J.E., Lazarus S.C., Lemanske R.F., Martin R.J., Peters S.P., Sorkness C., Szefler S.J. Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild Asthma. N. Engl. J. Med. 1996; 335(12)841–847
   PubMed Web of Science ®Google Scholar
• Pearlman D.S., Chervinsky P., LaForce C., Seltzer J.M., Southern D.L., Kemp J.P., Dockhorn R.J., Grossman J., Liddle R.F., Yancey S.W., Cocchetto D.M., Alexander W.J., Van As A. A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma. N. Engl. J. Med. 1992; 327(20)1420–1425
   PubMed Web of Science ®Google Scholar
• MacKinnon N.J., Flagstad M.S., Peterson C.R., Mesch-Beatty K. Disease Management Program for Asthma: Baseline Assessment of Resource Use. Am. J. Health Syst. Pharm. 1996; 53(5)535–541
   Google Scholar
• Lim T.K. Asthma Management: Evidence Based Studies and their Implications for Cost-Efficacy. Asian Pac. J. Allergy Immunol. 1999; 17(3)195–202
   Google Scholar
• Wilson S.R., Scamagas P., German D.F., Hughes G.W., Lulla S., Coss S., Chardon L., Thomas R.G., Starr-Schneidkraut N., Stancavage F.G., Arsham G.M. A Controlled Trial of Two Forms of Self-Management Education for Adults with Asthma. Am. J. Med. 1993; 94(6)564–576
   PubMed Web of Science ®Google Scholar
• Chambers C.V., Markson L., Diamond J.J., Lasch L., Berger M. Health Beliefs and Compliance with Inhaled Corticosteroids by Asthmatic Patients in Primary Care Practices. Respir. Med. 1999; 93(2)88–94
   PubMed Web of Science ®Google Scholar
• Vassallo R., Lipsky J.J. Theophylline: Recent Advances in the Understanding of Its Mode of Action and Uses in Clinical Practice. Mayo Clin. Proc. 1998; 73(4)346–354
   PubMed Web of Science ®Google Scholar
• Spitzer W.O., Suissa S., Ernst P., Horwitz R.I., Habbick B., Cockcroft D., Boivin J., McNutt M., Buist A.S., Rebuck A.S. The Use of Beta-Agonists and the Risk of Death and Near Death from Asthma. N. Engl. J. Med. 1992; 326(8)501–506
   PubMed Web of Science ®Google Scholar
• Haahtela T., Jarvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O., Sovijarvi A., Stenius-Aarniala B., Svahn T., Tammivaara R., Laitinen L.A. Comparison of a Beta2-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected Asthma. N. Engl. J. Med. 1991; 325(6)388–392
   PubMed Web of Science ®Google Scholar
• Blais L., Suissa S., Boivin J.F., Ernst P. First Treatment with Inhaled Corticosteroids and the Prevention of Admissions to Hospital for Asthma. Thorax 1998; 53(12)1025–1029
   Google Scholar
• Kauppinen R., Sintonen H., Tukiainen H. One-Year Economic Evaluation of Intensive vs. Conventional Patient Education and Supervision for Self-Management of New Asthmatic Patients. Respir. Med. 1998; 92(2)300–307
   PubMed Web of Science ®Google Scholar
• Cochrane M.G., Bala M.V., Downs K.E., Mauskopf J., Ben-Joseph R.H. Inhaled Corticosteroids for Asthma Therapy. Chest 2000; 117(2)542–550
   PubMed Web of Science ®Google Scholar
• Smith D.H., Malone D.C., Lawson K.A., Okamoto L.J., Battista C., Saunders W.B. A National Estimate of the Economic Costs of Asthma. Am. J. Respir. Crit. Care Med. 1997; 156(3 pt 1)787–793
   PubMed Web of Science ®Google Scholar
• Balkrishnan R., Norwood G.J., Anderson A. Outcomes and Cost Benefits Associated with the Introduction of Inhaled Corticosteroid Therapy in a Medicaid Population of Asthmatic Patients. Clin. Ther. 1998; 2(3)567–580
   Google Scholar